METHODS: The genotyping was performed with the polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) technique. Statistical analysis was performed using the χ2 test, within the 95% confidence interval. Odds ratios (OR) were calculated and Hardy-Weinberg equilibrium was verified for all control subjects and patients.
RESULTS: We found an association between the TNFSR1 -383 A>C genotype and the risk of lepromatous leprosy when leprosy patients were compared to controls (OR = 1.71, CI: 1.08-2.69, p = 0.02). Furthermore, it was also associated with the risk of LL in a dominant model (AC + CC vs AA, OR: 1.65, 95% CI: 1.05-2.057, p = 0.02). Similar genotype and allele frequencies for the SNPs TNFA - 308 G>A and TNFSR2 + 196 T>G were observed between leprosy patients and healthy subjects.
CONCLUSIONS: The TNFSR1 -383 A>C could be a potential marker for the identification of high-risk populations. However, additional studies, using larger samples of different ethnic populations, are required.
方法:使用基于聚合酶链反应的限制性片段长度多态性(PCR-RFLP)技术进行基因分型。统计学分析采用χ2检验,在95%置信区间内。计算赔率比(OR),并验证所有对照受试者和患者的Hardy-Weinberg平衡。
结果:我们发现TNFSR1-383A>C基因型与麻风病患者与对照组相比的麻风病风险之间存在关联(OR=1.71,CI:1.08-2.69,p=0.02)。此外,在主导模型(AC+CCvsAA,OR:1.65,95%CI:1.05-2.057,p=0.02)。在麻风病患者和健康受试者之间观察到SNPTNFA-308G>A和TNFSR2196T>G的相似基因型和等位基因频率。
结论:TNFSR1-383A>C可能是鉴定高危人群的潜在标记。然而,额外的研究,使用不同种族人群的更大样本,是必需的。